HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Phylloid hypomelanosis and mosaic trisomy 13: a new etiologically defined neurocutaneous syndrome].

Abstract
The term phylloid hypomelanosis is proposed to denote a new etiologically defined neurocutaneous syndrome. The hallmark of this trait is a pattern of hypopigmentation consisting of round or oval lesions, large asymmetrical areas reminiscent of the leaves of a begonia, as well as pear-shaped areas or oblong macules. The term phylloid pattern is derived from Greek phyllon=leaf and eidos=form. In 5 out of 6 cases in which cytogenetic findings were reported, a mosaic trisomy 13 or translocation trisomy 13 was found. All patients showed CNS defects with mental retardation. In addition, absence of corpus callosum, conductive hearing loss, choroidal and retinal coloboma,cranio-facial defects as well as brachydactyly,clinodactyly, camptodactyly and other skeletal anomalies were reported. In contrast to hypomelanosis of Ito which is associated with many different forms of genetic mosaicism, phylloid hypomelanosis most likely represents a cytogenetically rather uniform neurocutaneous phenotype.
AuthorsR Happle
JournalDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete (Hautarzt) Vol. 52 Issue 1 Pg. 3-5 (Jan 2001) ISSN: 0017-8470 [Print] Germany
Vernacular TitlePhylloide Hypomelanose und Mosaiktrisomie 13. Ein neues atiologisch definiertes neurokutanes Syndrom.
PMID11220235 (Publication Type: English Abstract, Journal Article)
Topics
  • Adolescent
  • Chromosomes, Human, Pair 13
  • Diagnosis, Differential
  • Female
  • Humans
  • Hypopigmentation (diagnosis, genetics)
  • Infant
  • Mosaicism
  • Neurocutaneous Syndromes (diagnosis, genetics)
  • Phenotype
  • Translocation, Genetic
  • Trisomy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: